当前位置: X-MOL 学术Complement Ther. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
Complementary Therapies in Medicine ( IF 3.6 ) Pub Date : 2020-11-20 , DOI: 10.1016/j.ctim.2020.102619
Laurel P Gibson 1 , Leah N Hitchcock 2 , Angela D Bryan 2 , L Cinnamon Bidwell 2
Affiliation  

Objectives

As the legal and cultural landscape surrounding cannabis use in the United States continues to evolve, more Americans are turning to cannabis to self-medicate a number of ailments, including migraines. The purpose of the present study was to examine patterns of cannabis use and its associated relief among migraineurs.

Design

Participants were N = 589 adult cannabis users living in states with full legal access. Using a cross-sectional design, participants completed an online survey assessing their cannabis use profiles, migraine experience, and self-reported relief from cannabis and non-cannabis treatments.

Results

161 participants (27.3 %) reported experiencing migraines. 76.4 % of migraineurs (N = 123) endorsed using cannabis to treat their migraines. 69.9 % (N = 86) of migraineurs using cannabis for migraine relief also endorsed using non-cannabis products (e.g., over-the-counter pain medication, triptans) to treat their migraines. Although their subjective health was similar (p = .17), migraineurs who endorsed using cannabis to treat their migraines reported more severe migraines compared to those who did not (p = .02). Migraineurs reported significantly more migraine relief from cannabis compared to non-cannabis products, even after controlling for migraine severity (p = .03). The majority of migraineurs using cannabis to treat their migraines were not medical cardholders (65.0 %), suggesting that these individuals were self-medicating in lieu of physician guidance.

Conclusions

The present study provides insight into the prevalence of cannabis use for migraine relief in a sample of cannabis users, and suggests that these migraineurs experience a high level of migraine relief from cannabis. Future studies are needed to determine the cannabis forms, potencies, and dosages that are most effective at treating migraine pain.



中文翻译:

大麻使用者的偏头痛经验、严重程度和治疗效果感知

目标

随着美国大麻使用的法律和文化环境不断发展,越来越多的美国人开始使用大麻来自我治疗包括偏头痛在内的一些疾病。本研究的目的是检查偏头痛患者使用大麻的模式及其相关缓解。

设计

参与者是N = 589 名生活在具有完全合法权限的州的成年大麻使用者。使用横断面设计,参与者完成了一项在线调查,评估他们的大麻使用情况、偏头痛经历以及自我报告的大麻和非大麻治疗缓解情况。

结果

161 名参与者 (27.3 %) 报告患有偏头痛。76.4% 的偏头痛患者 ( N = 123) 支持使用大麻治疗偏头痛。69.9 % ( N = 86) 使用大麻缓解偏头痛的偏头痛患者也支持使用非大麻产品(例如,非处方止痛药、曲坦类药物)来治疗偏头痛。尽管他们的主观健康状况相似 ( p = .17),但支持使用大麻治疗偏头痛的偏头痛患者报告的偏头痛比不使用大麻的患者更严重 ( p = .02)。偏头痛患者报告说,与非大麻产品相比,大麻对偏头痛的缓解效果明显更好,即使在控制了偏头痛严重程度后(p= .03)。大多数使用大麻治疗偏头痛的偏头痛患者不是医疗卡持有人 (65.0%),这表明这些人是在自我治疗而不是医生指导。

结论

本研究深入了解了大麻使用者样本中使用大麻来缓解偏头痛的流行情况,并表明这些偏头痛患者从大麻中获得了高度的偏头痛缓解。需要进一步研究以确定治疗偏头痛最有效的大麻形式、效力和剂量。

更新日期:2020-12-03
down
wechat
bug